187 related articles for article (PubMed ID: 22155602)
41. The frequency of cytochrome P450 2E1 polymorphisms in Black South Africans.
Chelule PK; Pegoraro RJ; Gqaleni N; Dutton MF
Dis Markers; 2006; 22(5-6):351-4. PubMed ID: 17264406
[TBL] [Abstract][Full Text] [Related]
42. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region.
Zhang JW; Yu WJ; Sheng XM; Chang FH; Bai TY; Lv XL; Wang G; Liu SZ
Asian Pac J Cancer Prev; 2014; 15(21):9203-10. PubMed ID: 25422202
[TBL] [Abstract][Full Text] [Related]
43. Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.
Su XL; Bin B; Cui HW; Ran MR
Chin J Cancer Res; 2011 Jun; 23(2):107-11. PubMed ID: 23483202
[TBL] [Abstract][Full Text] [Related]
44. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls.
Qian J; Song Z; Lv Y; Huang X
Tumour Biol; 2013 Aug; 34(4):2225-31. PubMed ID: 23636797
[TBL] [Abstract][Full Text] [Related]
45. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
46. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.
Niu Y; Yuan H; Leng W; Pang Y; Gu N; Chen N
Med Oncol; 2011 Mar; 28(1):182-7. PubMed ID: 20195803
[TBL] [Abstract][Full Text] [Related]
47. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone.
Marchand LL; Wilkinson GR; Wilkens LR
Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):495-500. PubMed ID: 10385138
[TBL] [Abstract][Full Text] [Related]
48. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation.
Oyama T; Kawamoto T; Mizoue T; Sugio K; Kodama Y; Mitsudomi T; Yasumoto K
Anticancer Res; 1997; 17(1B):583-7. PubMed ID: 9066584
[TBL] [Abstract][Full Text] [Related]
49. Genetic polymorphism of alcohol-metabolizing enzyme and alcohol dependence in Polish men.
Cichoz-Lach H; Celiński K; Wojcierowski J; Słomka M; Lis E
Braz J Med Biol Res; 2010 Mar; 43(3):257-61. PubMed ID: 20401433
[TBL] [Abstract][Full Text] [Related]
50. Localization of cytochrome P4502E1 enzyme in normal and cancerous gastric mucosa and association with its genetic polymorphism in unoperated and remnant stomach.
Kato S; Naito Z; Matsuda N; Onodera H; Sakurazawa N; Yamashita N; Kanazawa Y; Fujita I; Makino H; Uchida E
J Nippon Med Sch; 2011; 78(4):224-34. PubMed ID: 21869556
[TBL] [Abstract][Full Text] [Related]
51. Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma.
Brocic M; Supic G; Zeljic K; Jovic N; Kozomara R; Zagorac S; Zlatkovic M; Magic Z
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):586-93. PubMed ID: 21705789
[TBL] [Abstract][Full Text] [Related]
52. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract.
Bouchardy C; Hirvonen A; Coutelle C; Ward PJ; Dayer P; Benhamou S
Int J Cancer; 2000 Sep; 87(5):734-40. PubMed ID: 10925369
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
54. [Association of P450-2E1 and GSTM1 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity].
Wang T; Wang W; Wang ZY; Pan YY; Su QQ; He LX
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):585-7. PubMed ID: 19958676
[TBL] [Abstract][Full Text] [Related]
55. Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development.
Choi JY; Abel J; Neuhaus T; Ko Y; Harth V; Hamajima N; Tajima K; Yoo KY; Park SK; Noh DY; Han W; Choe KJ; Ahn SH; Kim SU; Hirvonen A; Kang D
Pharmacogenetics; 2003 Feb; 13(2):67-72. PubMed ID: 12563175
[TBL] [Abstract][Full Text] [Related]
56. A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.
Yang H; Zhou Y; Zhou Z; Liu J; Yuan X; Matsuo K; Takezaki T; Tajima K; Cao J
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2522-7. PubMed ID: 19706845
[TBL] [Abstract][Full Text] [Related]
57. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
58. Genetic polymorphism of CYP2E1 and digestive tract alcohol damage among Polish individuals.
Cichoz-Lach H; Partycka J; Nesina I; Wojcierowski J; Słomka M; Celiński K
Alcohol Clin Exp Res; 2006 May; 30(5):878-82. PubMed ID: 16634857
[TBL] [Abstract][Full Text] [Related]
59. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
Yu MW; Gladek-Yarborough A; Chiamprasert S; Santella RM; Liaw YF; Chen CJ
Gastroenterology; 1995 Oct; 109(4):1266-73. PubMed ID: 7557094
[TBL] [Abstract][Full Text] [Related]
60. Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus.
Li D; Dandara C; Parker MI
Clin Chem Lab Med; 2005; 43(4):370-5. PubMed ID: 15899651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
